Somatic mosaicism of the PI3K-AKT-MTOR pathway is associated with hemimegalencephaly in fetal brains

Kyoko Itoh1, Ritsuko Pooh2,3, Osamu Shimokawa3

  • 1Department of Pathology and Applied Neurobiology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.

Insights

Somatic mosaic mutations in PIK3CA and AKT1 cause fetal hemimegalencephaly. These mutations disrupt neural stem cell proliferation, differentiation, and migration, leading to abnormal brain development.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Genetics

Background:

  • Somatic activation of the PI3K-AKT-MTOR pathway is linked to cortical malformations like hemimegalencephaly.
  • Fetal cases of PI3K-AKT-MTOR-related brain malformations are rarely reported.

Observation:

  • Two fetal cases of hemimegalencephaly were identified, one with mosaic PIK3CA mutations and the other with mosaic AKT1 mutations.
  • Brains exhibited polymicrogyria and heterotopia, indicative of abnormal neural stem/progenitor cell proliferation, differentiation, and neuroblast migration.
  • Immunoreactivity for phosphorylated-S6 ribosomal protein (P-RPS6) was observed in various brain regions, confirming PI3K-AKT-MTOR pathway activation.

Findings:

  • Mosaic mutations in PIK3CA and AKT1 are associated with severe fetal brain malformations.
  • The PI3K-AKT-MTOR pathway is implicated in the pathogenesis of these developmental disorders.
  • Abnormal neural cell behavior, including proliferation and migration, underlies the observed cortical malformations.

Implications:

  • These findings enhance understanding of the mechanisms behind somatic mosaicism in brain development.
  • This research provides insights into the role of the PI3K-AKT-MTOR pathway in fetal cortical development.
  • Further investigation into these pathways may reveal therapeutic targets for brain malformation disorders.